Carson Wealth (CWM LLC)’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $309K | Buy |
11,953
+4,918
| +70% | +$127K | ﹤0.01% | 1844 |
|
|
2025
Q1 | $72K | Buy |
7,035
+6,884
| +4,559% | +$70.5K | ﹤0.01% | 2686 |
|
|
2024
Q4 | $2K | Sell |
151
-73
| -33% | -$967 | ﹤0.01% | 4570 |
|
|
2024
Q3 | $4K | Buy |
+224
| New | +$4K | ﹤0.01% | 4195 |
|
|
2024
Q2 | – | Sell |
-17
| Closed | – | – | 4810 |
|
|
2024
Q1 | $0 | Hold |
17
| – | – | ﹤0.01% | 4588 |
|
|
2023
Q4 | $0 | Hold |
17
| – | – | ﹤0.01% | 4386 |
|
|
2023
Q3 | $0 | Hold |
17
| – | – | ﹤0.01% | 4408 |
|
|
2023
Q2 | $0 | Hold |
17
| – | – | ﹤0.01% | 4356 |
|
|
2023
Q1 | $0 | Sell |
17
-39
| -70% | – | ﹤0.01% | 4236 |
|
|
2022
Q4 | $2K | Sell |
56
-289
| -84% | -$10.3K | ﹤0.01% | 3595 |
|
|
2022
Q3 | $17K | Buy |
345
+335
| +3,350% | +$16.5K | ﹤0.01% | 2333 |
|
|
2022
Q2 | $1K | Sell |
10
-165
| -94% | -$16.5K | ﹤0.01% | 3567 |
|
|
2022
Q1 | $14K | Buy |
175
+158
| +929% | +$12.6K | ﹤0.01% | 2298 |
|
|
2021
Q4 | $3K | Buy |
+17
| New | +$3K | ﹤0.01% | 2992 |
|
|
2021
Q2 | $2K | Hold |
7
| – | – | ﹤0.01% | 2653 |
|
|
2021
Q1 | $2K | Hold |
7
| – | – | ﹤0.01% | 2653 |
|
|
2020
Q4 | $2K | Hold |
7
| – | – | ﹤0.01% | 2653 |
|
|
2020
Q3 | $2K | Hold |
7
| – | – | ﹤0.01% | 2653 |
|
|
2020
Q2 | $2K | Hold |
7
| – | – | ﹤0.01% | 2653 |
|
|
2020
Q1 | $2K | Hold |
7
| – | – | ﹤0.01% | 2653 |
|
|
2019
Q4 | $2K | Hold |
7
| – | – | ﹤0.01% | 2653 |
|
|
2019
Q3 | $2K | Hold |
7
| – | – | ﹤0.01% | 2653 |
|
|
2019
Q2 | $2K | Hold |
7
| – | – | ﹤0.01% | 2653 |
|
|
2019
Q1 | $2K | Buy |
7
+4
| +133% | +$1.14K | ﹤0.01% | 2653 |
|
|
2018
Q4 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 1938 |
|